X0609 4 2026-10-07 0001658678 BioStem Technologies, Inc. BSEM 0001634730 Matuszewski Jason false C/O BIOSTEM TECHNOLOGIES, INC. 2836 CENTER PORT CIRCLE POMPANO BEACH FL 33064 true true true false Chief Executive Officer false Common Stock 2026-10-07 4 M false 250000 2.00 A 1553551 D Series A-1 Convertible Preferred Shares 2016-05-23 Common Stock 100 100 D Options (Right to Buy) 2.00 2026-10-07 4 M false 250000 0.00 D 2032-10-24 Common Stock 250000 2000000 D Options (Right to Buy) 10.05 2035-03-17 Common Stock 198807 198807 D Options (Right to Buy) 10.05 2035-10-13 Common Stock 40427 40427 D Options (Right to Buy) 5.50 2036-02-11 Common Stock 440529 440529 D Restricted Stock Units Common Stock 33874 33874 D Restricted Stock Units Common Stock 99901 99901 D Restricted Stock Units Common Stock 363636 363636 D The amount corrects the number of shares of common stock held by the Reporting Person, which over-reported a prior vesting of restricted stock units by one share in the Form 3 filed on August 14, 2026 and the Form 4 filed on September 17, 2026 due to an administrative error. The Series A-1 Convertible Preferred Shares is convertible in whole into shares of the Issuer's Common Stock on a one-to-one basis at the option of a majority of the holders of Series A-1 Convertible Preferred Shares. The Series A-1 Convertible Preferred Shares have no expiration date. Due to an administrative error, the Series A-1 Convertible Preferred Shares were inadvertently omitted from the Reporting Person's Form 3 filed on August 14, 2026. These options are fully vested and exercisable. These options vest according to the following schedule: 33% vested on March 17, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period. These options vest according to the following schedule: 33% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period. These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in equal quarterly installments over three year from the grant date (September 15, 2024). These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period. These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period. /s/ Katherine Gorrell, Attorney-in-Fact 2026-10-09